Compare PLYX & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLYX | WEYS |
|---|---|---|
| Founded | 2014 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 262.3M | 280.9M |
| IPO Year | N/A | 1995 |
| Metric | PLYX | WEYS |
|---|---|---|
| Price | $5.45 | $33.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 17.1K |
| Earning Date | 01-01-0001 | 03-03-2026 |
| Dividend Yield | N/A | ★ 3.40% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.41 |
| Revenue | N/A | ★ $276,169,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $13.28 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.20 | $25.51 |
| 52 Week High | $8.15 | $34.83 |
| Indicator | PLYX | WEYS |
|---|---|---|
| Relative Strength Index (RSI) | 52.51 | 54.08 |
| Support Level | $2.37 | $28.64 |
| Resistance Level | $7.43 | $34.06 |
| Average True Range (ATR) | 1.11 | 1.46 |
| MACD | 0.22 | -0.01 |
| Stochastic Oscillator | 59.79 | 68.12 |
Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small molecule drug candidates designed to address core pathological mechanisms common to LSDs.
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.